Clinical Data

Alzheimers research brain scientist magnifying glass questions neuro

NewAmsterdam links lipid drug to drop in Alzheimer's biomarker

The phase 3 sub-study tracked significant changes in an biomarker, adding to evidence that CETP inhibition may cut the risk of developing Alzheimer’s.

Nick Paul Taylor Jun 9, 2025 8:25am

Metsera posts amylin data, eyes monthly GLP-1 combo

Jun 9, 2025 7:00am

An artists depiction of DNA molecules made up of tiny particles

RegenXBio links DMD gene therapy to improved outcomes

Jun 5, 2025 8:52am

Cartoon of businessmen standing around a broken target

Vigil's rare brain disease drug flunks phase 2 study

Jun 4, 2025 9:45am

White arrow on a road pointing to the rising sun

J&J shares survival data on KLK2 bispecific in prostate cancer

Jun 2, 2025 6:40am

Merck takes middle dose of ROR ADC forward into phase 3

May 30, 2025 9:51am